Latest Financial Services News

Barramundi Limited (NZX:BRM) has reported the worst performance in its 20-year history, with a NZ$42.9 million net loss and a 17.0% fall in gross portfolio performance. The board is reviewing Fisher Funds’ management performance just weeks before its five-year agreement comes up for renewal.

Global X EURO STOXX 50 ETF delivered a higher annual profit and a sharp increase in net assets as investor applications accelerated. The audited report also highlights the fund’s sizeable exposure to European equities and euro-Australian dollar movements.

Global X Defence Tech ETF reported a $13.84 million loss for the year ended 30 June 2026, reversing a $7.50 million profit a year earlier. The result was driven by $14.48 million in net losses on investments and foreign exchange, even as investor applications lifted net assets to $112.56 million.

Global X Australian Bank Credit ETF more than doubled its net assets to $184 million in the year to 30 June 2026, while profit rose to $6.9 million. The audited report also shows a larger exposure to BBB-rated debt and a sharp increase in distributions payable.

Perennial Better Future Active ETF will be voluntarily wound up after a $2.601 million loss and a sharp contraction in its unitholder base. The fund’s Responsible Entity says it is unlikely to achieve the scale needed to operate economically, with the process expected to finish in financial year 2027.

Ziller Global Fund Active ETF reported a $1.77 million comprehensive loss for the year ended 30 June 2026, despite net assets rising to $10.9 million. The fund’s ASX debut, $10.2 million of applications and enlarged distribution came alongside a sharp investment loss.

Global X FANG+ ETF reported a sharp decline in annual profit, while its net asset value fell by more than 10% after 30 June as underlying technology stocks weakened. The audited fund still grew net assets to AUD1.606 billion and declared a 235.84 cents-per-unit distribution.

Global X S&P Biotech ETF (ASX:CURE) reported a AUD22.601 million profit for the year to 30 June 2026, reversing the prior year’s AUD2.863 million loss. The turnaround was driven overwhelmingly by gains in listed biotech securities and foreign exchange, rather than recurring income.

Global X S&P/ASX 200 Covered Call Complex ETF reported a sharp lift in annual profit as realised investment gains strengthened, while net assets passed $100 million. The fund declared 23.80 cents per unit for its June distribution, but its returns remain exposed to equity prices, options and a suspended holding valued at zero.

Global X Battery Tech & Lithium ETF delivered a sharply higher profit for the year ended 30 June 2026, driven by large fair-value gains across its listed equity portfolio. But the fund says its net asset value has since fallen by more than 10% as underlying battery and lithium investments weakened.

PIMCO Short Term Active Yield Fund grew net assets nearly eightfold to A$239.8 million in the year to 30 June 2026, as its ASX-listed EARN ETF class attracted new capital. All reported unit classes outperformed the fund’s cash-rate benchmark, although the ETF’s 3.11% return covers only nine months.

Betashares’ newly launched FTSE Global Infrastructure Shares Currency Hedged ETF reported $1.204 billion in profit and $8.08 billion in net assets for its first reporting year. The audited results also show strong gains across several established funds, alongside sharp post-year-end NAV movements in energy and gold miners.